Northern Trust’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-398,910
Closed -$1.97M 4493
2025
Q1
$1.97M Sell
398,910
-9,173
-2% -$29.1K ﹤0.01% 2935
2024
Q4
$1.2M Buy
408,083
+5,470
+1% +$22.4K ﹤0.01% 3308
2024
Q3
$1.9M Sell
402,613
-11,356
-3% -$51.2K ﹤0.01% 3037
2024
Q2
$1.59M Sell
413,969
-10,687
-3% -$48.2K ﹤0.01% 3024
2024
Q1
$2.27M Buy
424,656
+5,659
+1% +$26.6K ﹤0.01% 2896
2023
Q4
$1.79M Sell
418,997
-31,781
-7% -$97.7K ﹤0.01% 3058
2023
Q3
$1.77M Sell
450,778
-7,076
-2% -$46.4K ﹤0.01% 3008
2023
Q2
$4.63M Buy
457,854
+107,856
+31% +$1.14M ﹤0.01% 2544
2023
Q1
$3.57M Sell
349,998
-7,571
-2% -$86.6K ﹤0.01% 2655
2022
Q4
$3.35M Buy
357,569
+13,938
+4% +$197K ﹤0.01% 2716
2022
Q3
$5M Sell
343,631
-3,809
-1% -$56.5K ﹤0.01% 2482
2022
Q2
$4.59M Buy
347,440
+126,092
+57% +$1.72M ﹤0.01% 2574
2022
Q1
$3.78M Sell
221,348
-1,532
-0.7% -$26K ﹤0.01% 2745
2021
Q4
$5.71M Buy
+222,880
New +$6.95M ﹤0.01% 2609

Other funds holding TSVT

Northern Trust's TSVT Position: Q2 2025 in Review

Northern Trust sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 398,910 shares — an estimated $1.97M sold.

Northern Trust first reported a position in TSVT in Q4 2021 and held it in 14 quarters. The position peaked at $5.71M in Q4 2021. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Northern Trust reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Northern Trust sold 398,910 2seventy bio shares in Q2 2025, an estimated $1.97M.
  • Northern Trust first reported a position in 2seventy bio in Q4 2021 and held it in 14 quarters.
  • Northern Trust's 2seventy bio position peaked at $5.71M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Northern Trust's 13F filing for Q2 2025, filed 13 Aug 2025.